Phase II proof-of-concept study of atorvastatin in castration-resistant prostate cancer.
BJU international(2023)
摘要
Data from the SPECTRE study provide the first evidence of statin-mediated effects on CRPC and early sign of disease stabilization. Our data also highlight the possibility of altered tryptophan metabolism being associated with tumour response.
更多查看译文
关键词
#PCSM,#ProstateCancer,#uroonc,atorvastatin,castration resistant prostate cancer,cholesterol,prostate specific antigen,statins
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要